Evolent Health, Inc
EVH Healthcare Health Information Services
Evolent Health, Inc’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 26.6% from fiscal 2024. In the quarter to June 2026, revenue grew 46.9%, EPS grew 43.2%, free cash flow grew 58.7% and total debt rose 49.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow EVH
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
138.69 | 166.01 | 177.99 | 140.34 |
+8 more quarters Free account |
Receivables |
449.12 | 314.16 | 309.86 | 386.56 | |
Total current assets |
610.51 | 502.01 | 506.37 | 570.09 | |
Property, Plant, Equpment (Net) |
81.92 | 81.18 | 80.79 | 80.09 | |
Long-Term Investments |
11.54 | 11.69 | 11.67 | 11.60 | |
Goodwill and Intangible Assets (Total) |
1,248.86 | 1,264.12 | 1,279.42 | 1,699.07 | |
Long-term assets (Other) |
16.36 | 15.98 | 16.62 | 14.10 | |
Total non-current assets |
1,361.38 | 1,376.84 | 1,392.86 | 1,883.37 | |
Total Assets |
1,971.89 | 1,878.85 | 1,899.24 | 2,453.46 | |
Notes Payable |
— | — | — | 5.12 | |
Accounts Payable |
38.82 | 63.01 | 59.78 | 72.18 | |
Accrued Expenses |
43.90 | 45.06 | 65.76 | 60.89 | |
Current Revenue (Deferred) |
1.21 | 1.42 | 1.20 | 1.87 | |
Other current liabilities |
378.40 | 231.96 | 192.20 | 211.65 | |
Total current liabilities |
492.83 | 381.24 | 385.26 | 429.93 | |
Long Term Debt (Total) |
966.47 | 973.49 | 970.54 | 1,054.82 | |
Long Term Tax Liability (Deferred) |
9.94 | 7.57 | 7.51 | 10.16 | |
Non-current Liabilities (Other) |
117.00 | 117.00 | 116.92 | 111.89 | |
Total non-current liabilities |
1,095.84 | 1,101.22 | 1,098.78 | 1,181.30 | |
Total liabilities |
1,588.67 | 1,482.45 | 1,484.04 | 1,611.23 | |
Additional Paid In Capital |
1,817.41 | 1,802.22 | 1,793.40 | 1,791.06 | |
Common Stock (Net) |
1.19 | 1.19 | 1.18 | 1.18 | |
Retained Earnings |
(1,370.32) | (1,341.96) | (1,315.33) | (886.20) | |
Treasury Stock |
61.43 | 61.43 | 61.43 | 61.43 | |
Common Equity (Total) |
383.22 | 396.39 | 415.19 | 842.23 | |
Shareholders Equity (Total) |
383.22 | 396.39 | 415.19 | 842.23 | |
Shareholders Equity and Liabilities (Total) |
1,971.89 | 1,878.85 | 1,899.24 | 2,453.46 | |
Shares (Common) |
112.69 | 112.48 | 111.63 | 111.59 | |
Shareholders Equity (Tangible) |
(865.64) | (867.72) | (864.22) | (856.84) | |
Net Debt |
827.77 | 807.48 | 792.55 | 914.48 | |
Total Debt |
966.47 | 973.49 | 970.54 | 1,054.82 |